Drug Trial Radar · NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
Jul 14, 2028
Study completion Jul 14, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background glucose-lowering medication.
Conditions
- Type 2 Diabetes Mellitus
Interventions
ElecoglipronDrug
Elecoglipron is administered orally once daily.
DapagliflozinDrug
Dapagliflozin administered orally once daily.
Elecoglipron-matched placeboDrug
A placebo matching elecoglipron, administered orally once daily.
Dapagliflozin-matched placeboDrug
A placebo matching dapagliflozin, administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline to Week 40
Locations
149 sites in 13 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Not yet recruiting
Research Site
Daphne, Alabama · Not yet recruiting
Research Site
Lomita, California · Not yet recruiting
Research Site
Los Alamitos, California · Not yet recruiting
Research Site
San Diego, California · Suspended
Research Site
Walnut Creek, California · Suspended
Research Site
Englewood, Colorado · Not yet recruiting
Research Site
Bridgeport, Connecticut · Not yet recruiting
Research Site
Jacksonville, Florida · Not yet recruiting
Research Site
Orlando, Florida · Not yet recruiting
Research Site
Conyers, Georgia · Not yet recruiting
Research Site
Decatur, Georgia · Not yet recruiting
Research Site
Hinesville, Georgia · Not yet recruiting
Research Site
El Dorado, Kansas · Not yet recruiting
Research Site
Newton, Kansas · Not yet recruiting
Research Site
Lexington, Kentucky · Not yet recruiting
Research Site
Covington, Louisiana · Not yet recruiting
Research Site
Bowie, Maryland · Not yet recruiting
Research Site
Southfield, Michigan · Not yet recruiting
Research Site
Kansas City, Missouri · Not yet recruiting
Research Site
St Louis, Missouri · Not yet recruiting
Research Site
Las Vegas, Nevada · Not yet recruiting
Research Site
Anderson, South Carolina · Not yet recruiting
Research Site
Knoxville, Tennessee · Not yet recruiting
Research Site
Fort Worth, Texas · Suspended
Research Site
Irving, Texas · Not yet recruiting
Research Site
Renton, Washington · Not yet recruiting
Research Site
Buenos Aires, Argentina · Not yet recruiting
Research Site
Caba, Argentina · Not yet recruiting
Research Site
CABA, Argentina · Not yet recruiting
Research Site
Ciudad de Buenos Aires, Argentina · Not yet recruiting
Research Site
Mar del Plata, Argentina · Not yet recruiting
Research Site
San Nicolás, Argentina · Not yet recruiting
Research Site
San Vicente, Argentina · Not yet recruiting
Research Site
Santa Fe, Argentina · Not yet recruiting
Research Site
Baotou, China · Not yet recruiting
Research Site
Binzhou, China · Not yet recruiting
Research Site
Cangzhou, China · Not yet recruiting
Research Site
Changsha, China · Not yet recruiting
Research Site
Chengdu, China · Not yet recruiting
Showing 40 of 149 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.